BCRX logo

BioCryst Pharmaceuticals (BCRX) Shareholders equity

annual shareholders equity:

-$475.93M-$20.41M(-4.48%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual stockholders equity is -$475.93 million, with the most recent change of -$20.41 million (-4.48%) on December 31, 2024.
  • During the last 3 years, BCRX annual shareholders equity has fallen by -$368.95 million (-344.86%).
  • BCRX annual shareholders equity is now -651.70% below its all-time high of $86.27 million, reached on December 31, 2009.

Performance

BCRX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly shareholders equity:

-$451.93M+$24.01M(+5.04%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly stockholders equity is -$451.93 million, with the most recent change of +$24.01 million (+5.04%) on March 31, 2025.
  • Over the past year, BCRX quarterly shareholders equity has increased by +$24.24 million (+5.09%).
  • BCRX quarterly shareholders equity is now -549.09% below its all-time high of $100.63 million, reached on September 30, 2017.

Performance

BCRX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

BCRX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.5%+5.1%
3 y3 years-344.9%-175.2%
5 y5 years-1344.2%-10000.0%

BCRX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-344.9%at low-175.2%+5.1%
5 y5-year-1344.2%at low-690.7%+5.1%
alltimeall time-651.7%at low-549.1%+5.1%

BCRX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
-$451.93M(-5.0%)
Dec 2024
-$475.93M(+4.5%)
-$475.93M(+1.6%)
Sep 2024
-
-$468.56M(-1.5%)
Jun 2024
-
-$475.61M(-0.1%)
Mar 2024
-
-$476.17M(+4.5%)
Dec 2023
-$455.53M(+54.6%)
-$455.53M(+10.8%)
Sep 2023
-
-$410.99M(+5.7%)
Jun 2023
-
-$388.71M(+18.4%)
Mar 2023
-
-$328.29M(+11.4%)
Dec 2022
-$294.60M(+175.4%)
-$294.60M(+21.4%)
Sep 2022
-
-$242.66M(+13.8%)
Jun 2022
-
-$213.23M(+29.8%)
Mar 2022
-
-$164.22M(+53.5%)
Dec 2021
-$106.99M(+455.4%)
-$106.99M(-27.2%)
Sep 2021
-
-$147.04M(+38.6%)
Jun 2021
-
-$106.08M(+41.5%)
Mar 2021
-
-$74.99M(+289.3%)
Dec 2020
-$19.26M(-150.4%)
-$19.26M(-157.3%)
Sep 2020
-
$33.64M(-56.0%)
Jun 2020
-
$76.51M(+1997.2%)
Mar 2020
-
$3.65M(-90.5%)
Dec 2019
$38.25M(-22.3%)
$38.25M(-192.7%)
Sep 2019
-
-$41.25M(+348.7%)
Jun 2019
-
-$9.19M(-140.8%)
Mar 2019
-
$22.51M(-54.3%)
Dec 2018
$49.23M(-41.2%)
$49.23M(-32.4%)
Sep 2018
-
$72.87M(+57.8%)
Jun 2018
-
$46.18M(-25.6%)
Mar 2018
-
$62.05M(-25.9%)
Dec 2017
$83.77M(+5208.4%)
$83.77M(-16.8%)
Sep 2017
-
$100.63M(+318.0%)
Jun 2017
-
$24.08M(-37.5%)
Mar 2017
-
$38.53M(+2341.7%)
Dec 2016
$1.58M(-96.7%)
$1.58M(-60.5%)
Sep 2016
-
$3.99M(-70.2%)
Jun 2016
-
$13.39M(-51.8%)
Mar 2016
-
$27.80M(-41.8%)
Dec 2015
$47.72M(-36.9%)
$47.72M(-25.5%)
Sep 2015
-
$64.05M(-15.8%)
Jun 2015
-
$76.09M(+18.2%)
Mar 2015
-
$64.37M(-14.9%)
Dec 2014
$75.64M(-6817.1%)
$75.64M(-9.4%)
Sep 2014
-
$83.45M(-7.4%)
Jun 2014
-
$90.09M(-1674.2%)
Mar 2014
-
-$5.72M(+408.3%)
Dec 2013
-$1.13M(+148.0%)
-$1.13M(-133.0%)
Sep 2013
-
$3.41M(-137.7%)
Jun 2013
-
-$9.05M(+218.6%)
Mar 2013
-
-$2.84M(+525.6%)
Dec 2012
-$454.00K(-103.1%)
-$454.00K(-104.6%)
Sep 2012
-
$9.78M(-37.5%)
Jun 2012
-
$15.66M(-32.4%)
Mar 2012
-
$23.15M(+56.4%)
Dec 2011
$14.81M(-77.4%)
$14.81M(-43.1%)
Sep 2011
-
$26.04M(-33.7%)
Jun 2011
-
$39.27M(-27.5%)
Mar 2011
-
$54.17M(-17.3%)
Dec 2010
$65.50M(-24.1%)
$65.50M(-11.9%)
Sep 2010
-
$74.35M(-11.1%)
Jun 2010
-
$83.61M(-2.2%)
Mar 2010
-
$85.53M(-0.9%)
Dec 2009
$86.27M
$86.27M(+266.4%)
DateAnnualQuarterly
Sep 2009
-
$23.55M(-24.7%)
Jun 2009
-
$31.29M(-18.8%)
Mar 2009
-
$38.52M(-17.0%)
Dec 2008
$46.43M(-28.5%)
$46.43M(+32.6%)
Sep 2008
-
$35.01M(-17.5%)
Jun 2008
-
$42.42M(-21.8%)
Mar 2008
-
$54.22M(-16.5%)
Dec 2007
$64.91M(+206.8%)
$64.91M(-1.1%)
Sep 2007
-
$65.61M(+602.2%)
Jun 2007
-
$9.34M(-33.2%)
Mar 2007
-
$13.99M(-33.9%)
Dec 2006
$21.16M(-63.8%)
$21.16M(-29.5%)
Sep 2006
-
$30.02M(-32.4%)
Jun 2006
-
$44.39M(-16.6%)
Mar 2006
-
$53.22M(-8.9%)
Dec 2005
$58.44M(+99.2%)
$58.44M(+69.9%)
Sep 2005
-
$34.41M(-15.8%)
Jun 2005
-
$40.86M(-12.1%)
Mar 2005
-
$46.51M(+58.5%)
Dec 2004
$29.33M(+3.1%)
$29.33M(-14.5%)
Sep 2004
-
$34.32M(-12.9%)
Jun 2004
-
$39.41M(-9.3%)
Mar 2004
-
$43.43M(+52.7%)
Dec 2003
$28.45M(-29.1%)
$28.45M(-7.7%)
Sep 2003
-
$30.81M(-9.8%)
Jun 2003
-
$34.16M(-8.6%)
Mar 2003
-
$37.38M(-6.9%)
Dec 2002
$40.13M(-29.4%)
$40.13M(-6.4%)
Sep 2002
-
$42.86M(-7.3%)
Jun 2002
-
$46.21M(-10.0%)
Mar 2002
-
$51.34M(-9.6%)
Dec 2001
$56.81M(-7.6%)
$56.81M(-8.0%)
Sep 2001
-
$61.75M(+1.0%)
Jun 2001
-
$61.15M(+1.7%)
Mar 2001
-
$60.15M(-2.2%)
Dec 2000
$61.48M(-13.9%)
$61.48M(-13.6%)
Sep 2000
-
$71.14M(-1.9%)
Jun 2000
-
$72.56M(-2.2%)
Mar 2000
-
$74.22M(+4.0%)
Dec 1999
$71.40M(+157.8%)
$71.40M(+186.7%)
Sep 1999
-
$24.90M(-1.2%)
Jun 1999
-
$25.20M(-0.8%)
Mar 1999
-
$25.40M(-8.3%)
Dec 1998
$27.70M(+9.5%)
$27.70M(+22.0%)
Sep 1998
-
$22.70M(+14.6%)
Jun 1998
-
$19.80M(-13.2%)
Mar 1998
-
$22.80M(-9.9%)
Dec 1997
$25.30M(-28.5%)
$25.30M(-10.0%)
Sep 1997
-
$28.10M(-7.9%)
Jun 1997
-
$30.50M(-6.2%)
Mar 1997
-
$32.50M(-8.2%)
Dec 1996
$35.40M(+213.3%)
$35.40M(+4.7%)
Sep 1996
-
$33.80M(+89.9%)
Jun 1996
-
$17.80M(+1.7%)
Mar 1996
-
$17.50M(+54.9%)
Dec 1995
$11.30M(+0.9%)
$11.30M(-16.3%)
Sep 1995
-
$13.50M(-11.8%)
Jun 1995
-
$15.30M(+84.3%)
Mar 1995
-
$8.30M(-25.9%)
Dec 1994
$11.20M
$11.20M(-13.8%)
Sep 1994
-
$13.00M(+2.4%)
Jun 1994
-
$12.70M(-13.0%)
Mar 1994
-
$14.60M

FAQ

  • What is BioCryst Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual shareholders equity year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly shareholders equity year-on-year change?

What is BioCryst Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of BCRX is -$475.93M

What is the all time high annual shareholders equity for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual stockholders equity is $86.27M

What is BioCryst Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, BCRX annual stockholders equity has changed by -$20.41M (-4.48%)

What is BioCryst Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of BCRX is -$451.93M

What is the all time high quarterly shareholders equity for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly stockholders equity is $100.63M

What is BioCryst Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, BCRX quarterly stockholders equity has changed by +$24.24M (+5.09%)
On this page